Linda Melvin

Chairman and CEO

portrait-lindamelvinLinda Melvin is the founder and CEO of CharityMobi, Inc.  She is responsible for the strategic planning for the CharityMobi organization to provide World Health-Relief Aid for medically needy children in the United States and Internationally. She is the visionary developer of the USPTO registered CharityMobi® Happy to Help trade name. She is the creator of the USPTO registered MobiEHR ® proprietary product line of MobiEHR® Health ID cards and MobiEHR® M-Health Programs for children.

She is responsible for the strategic planning, evaluation and selection of countries for the deployment of the World Health Relief Aid programs. She is responsible for the development and implementation of the proprietary World Health-Relief Aid survey to identify child health needs to meet the 2015 WHO Millenium Health Goals, including providing the electronic health records in smart microchip cards to document donor supported medical relief aid provided to help children meet their 2015 WHO Millennium Health Goals.

Ms. Melvin has in the past been a non-profit business advisor to NGOs and charities, providing creative fundraising techniques utilizing mobile devices and contact-less donation technology. From 1998 to 2002 she was the founder and CEO of PDN, Inc., providing ComplyMD, a physician compliance monitoring system for managed care organizations. From 1996 to 1998 she was the founder and CEO of Physicians Data Network, LLC., providing web-enabled software programs for medical protocol analysis, compliance, and auditing for insurance companies, physicians and other subscribers. From 1981 to 1999 she was the founder and CEO of Satellite Health Resources, Inc, a health-care consulting company that maintained actuarial health care data, providing proprietary software applications for physicians, physical therapy facilities, and traumatic brain injury facilities.


CharityMobi. Inc. 1675 Chevron Way, STE 1 Sandy Springs, Goergia 30350 Tel: (770) 912-9333 Skype: charitymobi Youtube | Twitter | Facebook